ATLAS / Macro Radar / Reporting / IBRX

ImmunityBio, Inc. (IBRX) reporting calendar

ImmunityBio, Inc. files periodic reports with the SEC as IBRX on Nasdaq. Atlas tracks 44 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
29 Jul 2026 – 24 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
44

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open IBRX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001326110-26-000059
10-K31 Dec 202523 Feb 202654 days0001326110-26-000030
10-Q30 Sep 20255 Nov 202536 days0001326110-25-000139
10-Q30 Jun 20255 Aug 202536 days0001326110-25-000114
10-Q31 Mar 202512 May 202542 days0001326110-25-000071
10-K31 Dec 20243 Mar 202562 days0001326110-25-000033
10-Q30 Sep 202412 Nov 202443 days0001326110-24-000111
10-Q30 Jun 202412 Aug 202443 days0001326110-24-000103
10-Q31 Mar 20249 May 202439 days0001326110-24-000064
10-K31 Dec 202319 Mar 202479 days0001326110-24-000037
10-Q30 Sep 20239 Nov 202340 days0001326110-23-000147
10-Q30 Jun 20238 Aug 202339 days0001326110-23-000098
10-Q31 Mar 202311 May 202341 days0001326110-23-000064
10-K31 Dec 20221 Mar 202360 days0001326110-23-000018
10-Q30 Sep 20229 Nov 202240 days0001326110-22-000074
10-Q30 Jun 20228 Aug 202239 days0001326110-22-000058
10-Q31 Mar 202210 May 202240 days0001326110-22-000027
10-K31 Dec 20211 Mar 202260 days0001326110-22-000011
10-Q30 Sep 202112 Nov 202143 days0001326110-21-000009
10-Q30 Jun 202112 Aug 202143 days0001564590-21-044008
10-Q31 Mar 202114 May 202144 days0001564590-21-028010
10-K31 Dec 20204 Mar 202163 days0001564590-21-010945
10-Q30 Sep 20209 Nov 202040 days0001564590-20-052488
10-Q30 Jun 20207 Aug 202038 days0001564590-20-038096
10-Q31 Mar 202011 May 202041 days0001564590-20-024168
10-K31 Dec 201925 Mar 202085 days0001564590-20-012816
10-Q30 Sep 20195 Nov 201936 days0001564590-19-040363
10-Q30 Jun 20196 Aug 201937 days0001564590-19-029330
10-Q31 Mar 20198 May 201938 days0001564590-19-017179
10-K31 Dec 201813 Mar 201972 days0001564590-19-007562
10-Q30 Sep 20187 Nov 201838 days0001564590-18-028007
10-Q30 Jun 20186 Aug 201837 days0001564590-18-019420
10-Q31 Mar 20187 May 201837 days0001564590-18-011240
10-K31 Dec 201712 Mar 201871 days0001564590-18-005290
10-Q30 Sep 20177 Nov 201738 days0001564590-17-022217
10-Q30 Jun 20177 Aug 201738 days0001564590-17-015981
10-Q31 Mar 20178 May 201738 days0001564590-17-009421
10-K31 Dec 201615 Mar 201774 days0001564590-17-004430
10-Q30 Sep 201610 Nov 201641 days0001564590-16-028905
10-Q30 Jun 201615 Aug 201646 days0001564590-16-024275

Source: SEC EDGAR company submissions for CIK 0001326110. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.